Compounds of the formula I:or pharmaceutically acceptable salts thereof, wherein m, n. X, R1, R2, R3, R5, R6 and R7 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with LRRK2 receptor, such as Parkinsons disease.本發明係關於一種式I化合物:或其醫藥學上可接受之鹽,其中m、n、X、R1、R2、R3、R5、R6及R7係如本文所定義。亦揭示製造該等化合物之方法及使用該等化合物治療與LRRK2受體相關之疾病(諸如帕金森氏病(Parkinsons disease))的方法。